Indeed, there are examples of emerging medicines for children for the treatment of HIV and hepatitis C utilising these formulation approaches [ 55 , 56 , 57 , 58 ], and there appears to be an overall trend towards preservative-free, taste-masked solid oral dosage forms for paediatric patients globally [ 59 ].
← all excerpts
Assessing the Appropriateness of Formulations on the WHO Model List of Essential Medicines for Children: Development of a Paediatric Quality Target Product Profile Tool.
1
—
—